We are excited to announce our investment in @VergentBio's $21.5M Series B raise. Vergent is an innovative medical technology company developing an agent for the visualization of tumor tissue during cancer resections. Read about why we invested here: tinyurl.com/vergentinvestmen…
Congratulations to Windham portfolio company, @UH_Cares, on being awarded the ACO REACH model contract by CMS.
This contract paves the way for Upward to continue to offer services to individuals with complex needs while reducing costs. businesswire.com/news/home/2…
Congrats to @DELFIDiagnostic on their $225M Series B financing! We are proud to take part in this funding to support the continued development and commercialization of high-quality blood tests early cancer detection and treatment monitoring.
tinyurl.com/ys53hm3u
Proud to announce our new look at @windhamvp
We support healthcare through life saving, game changing investing, partnering with founders and leaders building innovative healthtech solutions.
Here's to helping great people build great companies. windhamvp.com/
Great outcome for PGDx -- $575M acquisition by Labcorp in move to strengthen oncology leadership position businesswire.com/news/home/2…
Proud that @windhamvp supported @PGDx_ starting with their Series A financing and continuing with their most recent growth round. Congrats to Luis Diaz, @velculescu, Megan Bailey and the rest of the @PGDx team!
Windham Venture Partners retweeted
Today we announce something BIG that will help us continue on our mission to revolutionize by-the-glass consumption of #Champagne and #SparklingWine. 🥂 Drumroll, please.... bit.ly/3DubSld
Windham Venture Partners retweeted
Who will make the vaccine next time?
These extraordinary times and circumstances of call for extraordinary measures.
The US supports the waiver of IP protections on COVID-19 vaccines to help end the pandemic and we’ll actively participate in @WTO negotiations to make that happen.
Great accomplishment!
@chromacodeinc Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition prn.to/3eX6nm3
Windham Venture Partners retweeted
Excited to share that CVRx has been named to the #Fierce15 this year! We are honored that @FierceMedTech sees the potential for #Barostim to become an important therapy to treat #heartfailure symptoms.
Please see the article & interview with @cvrxceo
fiercebiotech.com/special-re…
Excited to have helped seed Delfi and partner w/Victor Velculescu, great things to come:
Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biops... prn.to/3bwiW5P
Finalists Selected in $6 Million XPRIZE Rapid Covid Testing Competition to Help Restart Global Economy | Business Wire businesswire.com/news/home/2…
Windham Venture Partners retweeted
Excited to share that #CMS has approved Transitional Pass-Through (TPT) payment for CVRx #Barostim for #heartfailure! TPT will be effective Jan 1 2021 and provide incremental reimbursement in the outpatient setting! #EPeeps #Cardiotwitter
PR: bit.ly/3mHLNHa
Personal Genome Diagnostics Announces Medicare Coverage of PGDx elio™ tissue complete Assay for Patients with Advanced Cancer | Business Wire businesswire.com/news/home/2…
SubjectWell Recruits Patients for COVID-19 Vaccine Clinical Trials, Works to Address Lack of Racial Diversity in Patient Recruitment To Date subjectwell.com/news/subject…
Important milestone! Congrats to the great team at @PGDx_
We are proud to announce the @US_FDA landmark clearance for PGDx elio™ tissue complete, the first and only FDA-cleared clinical NGS diagnostic kit and accompanying software to provide rapid and comprehensive tumor profiling. bit.ly/2VYpBfM
Windham Venture Partners retweeted
There comes a moment when elective care becomes essential and I believe we can’t forget about our non-COVID19 patients. Great piece on the same by @LisaRosenbaum17 in @NEJM.
nejm.org/doi/full/10.1056/NE…
Windham Venture Partners retweeted
... crucial surgical technologies, and the health care professionals who helped make the case that we need to work responsibly to get these patients the care they need.
Windham Venture Partners retweeted
... important to the patient’s health, and must often be performed. As the plan is implemented, we must ensure that patients who need life-saving care can receive it. We thank the White House task force for working with AdvaMed, our member companies who manufacture these ...











